Scientists and Farmers See Ways To Make AI Useful to Agriculture
In a groundbreaking, first-of-its kind event, university scientists, engineers, producers, government agencies and industry officials from throughout the South met at Auburn University to brainstorm ways to use artificial intelligence to help farmers.
World Glaucoma Week: A Retina Specialist’s Guide to Recent Innovations in Glaucoma
Ophthalmologists and researchers have made great strides in the management of glaucoma. From implants and robotics to proper administration of eye drops, glaucoma is treated more effectively than ever. This article highlights some of the latest discoveries in glaucoma, including work by UF startup and Sid Martin Biotech company TearClear.
Medication Safety 2.0: Advances in Adherence Technology
A recently published review on emerging smart technology innovations in the health care sector suggests various advanced technologies and methods may now significantly improve medication adherence.1 Two significant advances have been the ability to measure medication adherence and safety issues with medication event monitoring systems (MEMS) and smart blister packs containing radio frequency identification technology.
National Academy of Engineering Selects Professor Michele Manuel for Highest Professional Honor
The National Academy of Engineering has elected UF professor Michele Manuel, Ph.D., to join the organization’s ranks, among the highest professional honors in engineering for those who have distinguished themselves in academia, private industry, or government agencies.
Lacerta Therapeutics Expands Executive Leadership Team
UF startup Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: illustrating Lacerta’s commitment to developing a constellation of gene-based therapies.
Cannabix Technologies Presents FAIMS Marijuana Breathalyzer Technology at the Texas Impaired Driving Forum
UF startup Cannabix Technologies Inc., presented key innovations for first-of-its-kind marijuana breath detection technology. This comes at a time when legislators are grappling with the ever-increasing problem of drugged driving.
GrowFL Announces Lacerta Therapeutics as an Honoree: 11th Annual Florida Companies to Watch
Lacerta Therapeutics is pleased to be among the top 50 second-stage companies in Florida selected as an 11th Annual GrowFL Florida Companies to Watch honoree, a statewide competition that identifies companies expected to see significant growth over the next several years.
Fitness App FitOn Raises $40M, Acquires Corporate Wellness Platform Peerfit
Digital fitness and wellness company FitOn has raised $40 million in Series C funding led by Delta-v Capital, the company announced on Tuesday. FitOn is also expanding its reach in wellness by acquiring Tampa-based corporate wellness platform Peerfit, a UF startup that incubated at UF Innovate | Accelerate at The Hub.
Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment
The U.S. Department of Defense (DOD) has awarded UF startup Ology Bioservices, Inc. (Ology), a wholly-owned subsidiary of Resilience, a contract valued as much as $250 million for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxins (BoNT).
TearClear Announces Initiation of TC-002 Latanoprost Ophthalmic Solution Phase 3 Trial
TearClear has announced the TC-002 phase 3 trial has been successfully initiated. TearClear’s phase 3 trial (CLEAR Study) is a prospective, double-masked, randomized, multicenter, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive efficacy of TC-002 ophthalmic solution (TearClear Preservative-Free Latanoprost Ophthalmic Solution 0.005%) compared to marketed Latanoprost ophthalmic solution 0.005%.
